Last edition
News about
SPARC Announces Major Workforce Reduction, Shifts to Hybrid R&D Model
Sun Pharma Advanced Research Company Ltd. (SPARC) has announced plans to reduce its workforce by around 40% as part of a broader restructuring aimed at streamlining operations and optimising costs. The impact will be most pronounced in the United States, where more than 80% of employees are expected to be laid off, according to company disclosures.
Bayer Partners with Souffle Therapeutics to Develop Heart-Targeted siRNA Therapy
Bayer and Soufflé Therapeutics, a biotechnology company focused on developing cell-selective genetic medicines, have entered into a strategic collaboration and global licensing agreement to advance a heart-targeted small interfering RNA (siRNA) therapy for a rare form of dilated cardiomyopathy.
Sharp Sterile Manufacturing Expands Capacity Via USD 28 Million Investment
With the new investment, Sharp Sterile Manufacturing aims to scale up throughput by adding an automated isolated filling line to support faster batch production.
Sky Labs's Ring-Type Blood Pressure Monitor Secures CE-MDR Certification in Europe
Certification clears Cart Platform for European market entry, validating cuffless blood pressure monitoring technology and supporting global expansion plans.
GSK Secures EU Approval for Simplified Shingrix Presentation in Prefilled Syringe
GSK plc announced that the European Commission (EC) has approved a new prefilled syringe presentation of Shingrix, the company’s recombinant zoster vaccine (RZV), aimed at simplifying administration for healthcare professionals across the European Union.
Newron Strengthens Evenamide IP Portfolio with New European Patent Approval
Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on developing innovative therapies for disorders of the central and peripheral nervous system, announced that the European Patent Office (EPO) has granted an additional patent covering its lead drug candidate, evenamide.
WHO Updates HIV Treatment and TB Prevention Guidelines
New WHO recommendations strengthen antiretroviral therapy choices, vertical HIV transmission management and TB preventive treatment to improve outcomes and accelerate progress toward ending AIDS globally.
Remedy Cell Launches Phase 1b Trial of RC-0315 in IPF
First-in-human study evaluates safety and tolerability of intra-bronchial RC-0315, a cell-derived therapy aimed at reducing fibrosis and restoring lung function in idiopathic pulmonary fibrosis patients.
Common Cholesterol Drug Shows Promise Against Drug-Resistant Breast Cancer
Korea University researchers show the cholesterol drug inhibits Mcl-1, suppresses metastasis, and restores chemotherapy sensitivity in preclinical models of aggressive TNBC.
Variant Bio partners with Boehringer Ingelheim for Research on Kidney Disease
The multi-year collaboration with Boehringer Ingelheim will leverage Variant Bio’s AI-powered Inference platform to identify novel kidney disease drug targets, with financial terms including upfront, licence and milestone payments that could exceed USD 120 million.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy